BPG is committed to discovery and dissemination of knowledge
Letter to the Editor
Copyright ©The Author(s) 2025.
World J Virol. Sep 25, 2025; 14(3): 109614
Published online Sep 25, 2025. doi: 10.5501/wjv.v14.i3.109614
Figure 1
Figure 1 Epidemiological distribution of hepatitis C virus-affected people across the World Health Organization. HCV: Hepatitis C virus.
Figure 2
Figure 2 The Centers for Disease Control and Prevention recommends following the algorithm for managing patients who screen positive on antibody-based screening tests. 1Hepatitis C virus (HCV) RNA testing or follow-up testing for HCV antibodies is recommended if the patient is exposed to HCV in the prior 6 months. Testing for HCV RNA can be considered for patients who are immune compromised. 2HCV antibody assay can be considered to differentiate false positive from past resolved infection. Also, if clinical evidence of HCV infection is present or patient had exposure to HCV in prior 6 months then HCV RNA should be carried out. HCV: Hepatitis C virus.